🧠 Unlocking Communication: Cognixion Launches Clinical Study Integrating Noninvasive BCI with Apple Vision Pro
Cognixion is taking a bold step toward making brain–computer interface (BCI) technology more accessible than ever. We have launched a new clinical study integrating our noninvasive EEG-based BCI with the Apple Vision Pro, with the goal of enabling individuals with severe speech and mobility impairments to communicate and interact through thought, gaze, or head movement, without surgery.
Breaking Barriers with Accessible Neurotechnology
The study will evaluate how Cognixion’s Nucleus™ bio-sensing hub and advanced EEG montage can work alongside Apple Vision Pro’s powerful accessibility features. Including Eye Tracking and Dwell Control to create a new model of hands-free, voice-free communication.
Participants will include individuals affected by ALS (amyotrophic lateral sclerosis), spinal cord injury (SCI), stroke, and traumatic brain injury (TBI). Our study’s primary goal is to enable natural, conversational communication between participants and their caregivers, families, and communities — restoring independence through inclusive innovation.
Designed for Connection, Not Surgery
“Apple has set a global standard by making accessibility integral to every device, and Apple Vision Pro extends that commitment to spatial computing,” said Andreas Forsland, Founder and CEO of Cognixion.
“By exploring how Cognixion's non-invasive BCI technology and AI applications can work with Apple's accessibility features, we hope to unlock new levels of independence and connection for people living with ALS, spinal cord injuries, stroke, and traumatic brain injuries. Our focus is on improving lives today without requiring surgery or tethered systems.”
This integration will allow researchers to test new assistive pathways, leveraging combinations of brain signals, eye gaze, and head pose, that enable faster, more natural communication and computer interaction.
A Shared Vision for Accessibility
In the United States alone, over 14 million people live with chronic neurological conditions, and nearly 1 million more are diagnosed each year. Of these, more than 750,000 individuals experience limited access to reliable communication tools due to paralysis or speech impairment.
Our work at Cognixion aligns with Apple’s philosophy that accessibility is not an add-on — it’s a fundamental right. Together, this study underscores how neurotechnology and spatial computing can combine to expand independence and improve quality of life.
“This study is about understanding the patient experience — what happens when advanced accessibility features meet new neural input methods,” said Chris Ullrich, Cognixion’s Chief Technology Officer and principal investigator for the clinical trial. “We’re learning from each participant’s lived experience to design solutions that are meaningful and delightful.”
Building Toward the Future
Beyond communication, we plan to explore Assisted Reality use cases. From controlling mobility devices to accessing entertainment, education, and work, all through a seamless, noninvasive interface.
This study marks one of the first clinical explorations of a noninvasive EEG-based BCI integrated with Apple Vision Pro, setting the stage for a new era in inclusive technology. Following this feasibility study, Our clinical trial is currently underway. To learn more click here.
Get Involved
Individuals interested in participating in the study can reach out to clinicaltrials@cognixion.com with “Cognixion-spatial computing study” in the subject line.